A detailed history of Citigroup Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Citigroup Inc holds 570,123 shares of ELAN stock, worth $8.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
570,123
Previous 145,379 292.16%
Holding current value
$8.16 Million
Previous $2.37 Million 247.68%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$12.93 - $18.45 $5.49 Million - $7.84 Million
424,744 Added 292.16%
570,123 $8.23 Million
Q1 2024

May 10, 2024

BUY
$14.37 - $16.46 $315,148 - $360,984
21,931 Added 17.77%
145,379 $2.37 Million
Q4 2023

Feb 09, 2024

BUY
$8.6 - $14.94 $268,560 - $466,546
31,228 Added 33.86%
123,448 $1.84 Million
Q3 2023

Nov 09, 2023

SELL
$9.81 - $12.62 $1.3 Million - $1.67 Million
-132,612 Reduced 58.98%
92,220 $1.04 Million
Q2 2023

Aug 10, 2023

SELL
$8.08 - $10.37 $2.57 Million - $3.3 Million
-317,886 Reduced 58.57%
224,832 $2.26 Million
Q1 2023

May 11, 2023

BUY
$8.79 - $14.58 $2.84 Million - $4.71 Million
322,953 Added 146.95%
542,718 $5.1 Million
Q4 2022

Feb 09, 2023

SELL
$11.49 - $13.65 $2.46 Million - $2.92 Million
-214,021 Reduced 49.34%
219,765 $2.69 Million
Q3 2022

Nov 10, 2022

SELL
$12.41 - $32.42 $474,285 - $1.24 Million
-38,218 Reduced 8.1%
433,786 $5.38 Million
Q2 2022

Aug 10, 2022

SELL
$19.63 - $26.62 $28.5 Million - $38.6 Million
-1,451,750 Reduced 75.46%
472,004 $9.27 Million
Q1 2022

May 12, 2022

BUY
$24.65 - $29.0 $7.91 Million - $9.31 Million
320,895 Added 20.02%
1,923,754 $50.2 Million
Q4 2021

Feb 10, 2022

BUY
$27.74 - $34.09 $2.34 Million - $2.88 Million
84,485 Added 5.56%
1,602,859 $45.5 Million
Q3 2021

Nov 10, 2021

BUY
$29.2 - $36.72 $44.3 Million - $55.8 Million
1,518,374 New
1,518,374 $48.4 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.79B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.